{"title":"使用多粘菌素 B 引起的皮肤瘀点疹:罕见病例报告","authors":"Emel Akbudak Yerdelen , Ayşe Günay , Seda Yılmaz , Abdulkadir Baştürk","doi":"10.1016/j.htct.2024.04.024","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>Polymyxins are bactericidal drugs that bind to lipopolysaccharides (LPS) and phospholipids in the outer cell membrane of gram-negative bacteria (1,2). The most important side effect of intravenous polymyxins is nephrotoxicity, neurotoxicity. Hypersensitivity reactions including rash, itching, urticaria, and fever have also been reported. It can also cause skin hyperpigmentation (3,4,5). We will present the rash thought to have developed due to polymyxin in an elderly patient diagnosed with AML.</p></div><div><h3>Case report</h3><p>A 77-year-old male patient diagnosed with AML was admitted to the hospital for a chemotherapy session. After the initial examination, he was hospitalized due to complaints of dyspnea, weakness, and cough. Polymyxin B was started upon recommendation to the patient, who was consulted with the department of chest diseases and infectious diseases regarding his current infection status.</p><p>Results: During the follow-up, petechial rashes and itching began to occur on both lower legs, starting from the ankle and spreading upwards, and it was noted that the rash and itching occurred after the use of polymyxin B. After the suspected drug was discontinued, the itching gradually decreased, and the rash was observed to become widespread and change color. The patient's rashes were photographed, and his follow-up continued and after comleting the treatment he was discharged.</p></div><div><h3>Conclusion</h3><p>In this multidrug-resistant Gram-negative bacteria era, the use of polymyxines has spread. Due to the use of these agents, adverse events such as pruritus, maculapapular rashes, and urticaria may occur (6). Patients should be observed for hypersensitivity reactions related to polymyxin B use, and the cause of these symptoms should be enlightened with the right anamnesis.</p></div>","PeriodicalId":12958,"journal":{"name":"Hematology, Transfusion and Cell Therapy","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2531137924001068/pdfft?md5=2bd5e03ce2f9abd523285dcf369af56e&pid=1-s2.0-S2531137924001068-main.pdf","citationCount":"0","resultStr":"{\"title\":\"PETECHIAL RASH ON THE SKIN DUE TO THE USE OF POLYMYXIN B: A RARE CASE REPORT\",\"authors\":\"Emel Akbudak Yerdelen , Ayşe Günay , Seda Yılmaz , Abdulkadir Baştürk\",\"doi\":\"10.1016/j.htct.2024.04.024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>Polymyxins are bactericidal drugs that bind to lipopolysaccharides (LPS) and phospholipids in the outer cell membrane of gram-negative bacteria (1,2). The most important side effect of intravenous polymyxins is nephrotoxicity, neurotoxicity. Hypersensitivity reactions including rash, itching, urticaria, and fever have also been reported. It can also cause skin hyperpigmentation (3,4,5). We will present the rash thought to have developed due to polymyxin in an elderly patient diagnosed with AML.</p></div><div><h3>Case report</h3><p>A 77-year-old male patient diagnosed with AML was admitted to the hospital for a chemotherapy session. After the initial examination, he was hospitalized due to complaints of dyspnea, weakness, and cough. Polymyxin B was started upon recommendation to the patient, who was consulted with the department of chest diseases and infectious diseases regarding his current infection status.</p><p>Results: During the follow-up, petechial rashes and itching began to occur on both lower legs, starting from the ankle and spreading upwards, and it was noted that the rash and itching occurred after the use of polymyxin B. After the suspected drug was discontinued, the itching gradually decreased, and the rash was observed to become widespread and change color. The patient's rashes were photographed, and his follow-up continued and after comleting the treatment he was discharged.</p></div><div><h3>Conclusion</h3><p>In this multidrug-resistant Gram-negative bacteria era, the use of polymyxines has spread. Due to the use of these agents, adverse events such as pruritus, maculapapular rashes, and urticaria may occur (6). Patients should be observed for hypersensitivity reactions related to polymyxin B use, and the cause of these symptoms should be enlightened with the right anamnesis.</p></div>\",\"PeriodicalId\":12958,\"journal\":{\"name\":\"Hematology, Transfusion and Cell Therapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2531137924001068/pdfft?md5=2bd5e03ce2f9abd523285dcf369af56e&pid=1-s2.0-S2531137924001068-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hematology, Transfusion and Cell Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2531137924001068\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology, Transfusion and Cell Therapy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2531137924001068","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
多粘菌素是一种杀菌药物,能与革兰氏阴性细菌细胞外膜上的脂多糖(LPS)和磷脂结合(1,2)。静脉注射多粘菌素最重要的副作用是肾毒性和神经毒性。过敏反应包括皮疹、瘙痒、荨麻疹和发热也有报道。它还会导致皮肤色素沉着(3,4,5)。我们将介绍一名被诊断为急性髓细胞性白血病的老年患者因多粘菌素而出现的皮疹。初步检查后,他因主诉呼吸困难、虚弱和咳嗽而住院。根据患者的建议开始使用多粘菌素 B,并就其目前的感染状况咨询了胸科和传染科:随访期间,患者双下肢开始出现瘀点状皮疹和瘙痒,从脚踝开始向上蔓延,并注意到皮疹和瘙痒是在使用多粘菌素 B 后出现的。对患者的皮疹进行了拍照,并继续对其进行随访,在完成治疗后,患者痊愈出院。由于这些药物的使用,可能会出现瘙痒、斑丘疹和荨麻疹等不良反应(6)。应观察患者是否出现与使用多粘菌素 B 相关的超敏反应,并通过正确的病史资料了解这些症状的原因。
PETECHIAL RASH ON THE SKIN DUE TO THE USE OF POLYMYXIN B: A RARE CASE REPORT
Objective
Polymyxins are bactericidal drugs that bind to lipopolysaccharides (LPS) and phospholipids in the outer cell membrane of gram-negative bacteria (1,2). The most important side effect of intravenous polymyxins is nephrotoxicity, neurotoxicity. Hypersensitivity reactions including rash, itching, urticaria, and fever have also been reported. It can also cause skin hyperpigmentation (3,4,5). We will present the rash thought to have developed due to polymyxin in an elderly patient diagnosed with AML.
Case report
A 77-year-old male patient diagnosed with AML was admitted to the hospital for a chemotherapy session. After the initial examination, he was hospitalized due to complaints of dyspnea, weakness, and cough. Polymyxin B was started upon recommendation to the patient, who was consulted with the department of chest diseases and infectious diseases regarding his current infection status.
Results: During the follow-up, petechial rashes and itching began to occur on both lower legs, starting from the ankle and spreading upwards, and it was noted that the rash and itching occurred after the use of polymyxin B. After the suspected drug was discontinued, the itching gradually decreased, and the rash was observed to become widespread and change color. The patient's rashes were photographed, and his follow-up continued and after comleting the treatment he was discharged.
Conclusion
In this multidrug-resistant Gram-negative bacteria era, the use of polymyxines has spread. Due to the use of these agents, adverse events such as pruritus, maculapapular rashes, and urticaria may occur (6). Patients should be observed for hypersensitivity reactions related to polymyxin B use, and the cause of these symptoms should be enlightened with the right anamnesis.